PLIANT THERAPEUTICS INC's ticker is PLRX and the CUSIP is 729139105. A total of 139 filers reported holding PLIANT THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.37 and the average weighting 1.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $36,983,914 | -4.3% | 2,132,867 | 0.0% | 13.93% | -60.1% |
| Q2 2023 | $38,647,550 | -31.9% | 2,132,867 | 0.0% | 34.92% | -13.9% |
| Q1 2023 | $56,734,262 | +37.6% | 2,132,867 | 0.0% | 40.55% | +131.3% |
| Q4 2022 | $41,228,319 | -7.5% | 2,132,867 | 0.0% | 17.53% | -32.7% |
| Q3 2022 | $44,556,000 | +160.8% | 2,132,867 | 0.0% | 26.04% | +131.8% |
| Q2 2022 | $17,084,000 | +14.3% | 2,132,867 | 0.0% | 11.23% | +105.1% |
| Q1 2022 | $14,951,000 | -48.1% | 2,132,867 | 0.0% | 5.48% | -33.9% |
| Q4 2021 | $28,794,000 | -20.0% | 2,132,867 | 0.0% | 8.28% | +1.4% |
| Q3 2021 | $36,003,000 | -42.0% | 2,132,867 | 0.0% | 8.17% | -72.4% |
| Q2 2021 | $62,109,000 | -26.0% | 2,132,867 | 0.0% | 29.57% | -4.3% |
| Q1 2021 | $83,886,000 | +73.1% | 2,132,867 | 0.0% | 30.90% | +98.8% |
| Q4 2020 | $48,459,000 | +0.3% | 2,132,867 | 0.0% | 15.54% | -6.5% |
| Q3 2020 | $48,309,000 | -30.2% | 2,132,867 | 0.0% | 16.63% | -47.9% |
| Q2 2020 | $69,233,000 | – | 2,132,867 | – | 31.90% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 339,160 | $5,881,034 | 100.00% |
| CHI Advisors LLC | 3,014,199 | $52,266,211 | 20.72% |
| TRV GP IV, LLC | 2,132,867 | $36,983,914 | 13.93% |
| GREAT POINT PARTNERS LLC | 1,755,184 | $30,434,891 | 5.54% |
| First Light Asset Management, LLC | 2,933,260 | $50,862,728 | 4.83% |
| Deep Track Capital, LP | 5,500,000 | $95,370,000 | 3.68% |
| Casdin Capital, LLC | 1,577,108 | $27,347,053 | 3.03% |
| Fernwood Investment Management, LLC | 379,702 | $6,584,033 | 2.37% |
| Redmile Group, LLC | 2,678,099 | $46,438,237 | 2.21% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 250,409 | $4,342,092 | 1.32% |